Is Cogent Biosciences, Inc. (COGT) a Buy, Sell, or Hold?
NASDAQ : COGT
Cogent Biosciences, Inc. — Institutional Ownership
$38.93 USD
-$2.43 (-5.88%)
- Volume
- 1.52M
- Average Volume
- 2.45M
- Market Capitalization
- $6.65B
- P/E Ratio
- -12.64
- Dividend Yield
- 0.00%
- Price Target
- $48.50
- Year High
- $43.73
- Year Low
- $10.38
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $15.14
Institutional Ownership Summary
Institutional Ownership %
8.28%
Investors Holding
47
change: -270 | last: 317
Increased Positions
25
change: -172 | last: 197
Reduced Positions
11
change: -72 | last: 83
New Positions
12
change: -67 | last: 79
Sold Positions
272
change: 231 | last: 41
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -59.2974 | last: 0.593
Total Invested
216.02M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-14 | Deerfield Mgmt, L.P. | 9.04M | 5.29% |
| 2026-03-31 | Fairmount Funds Management LLC | 15.36M | 8.60% |
| 2026-03-31 | Fairmount Healthcare Fund II GP LLC | 15.36M | 8.60% |
| 2026-03-26 | The Vanguard Group | - | 0.00% |
| 2026-02-17 | Kynam Capital Management, LP | 6.17M | 4.33% |
| 2026-02-17 | Commodore Capital LP | 2.8M | 1.80% |
| 2026-01-30 | The Vanguard Group | 11.51M | 7.50% |
| 2026-01-22 | Fairmount Healthcare Fund II GP LLC | 16.26M | 9.90% |
| 2026-01-22 | Fairmount Funds Management LLC | 16.26M | 9.90% |
| 2026-01-21 | BlackRock, Inc. | 11.37M | 6.50% |
| 2026-01-21 | BlackRock, Inc. | 11.37M | 6.50% |
| 2025-11-17 | Fairmount Healthcare Fund II GP LLC | 15.88M | 9.90% |
| 2025-11-17 | Fairmount Funds Management LLC | 15.88M | 9.90% |
| 2025-11-14 | Commodore Capital LP | 10.21M | 7.20% |
| 2025-11-14 | Kynam Capital Management, LP | 7.89M | 5.54% |
| 2025-11-14 | Paradigm BioCapital Advisors LP | 3.16M | 2.30% |
| 2025-11-14 | TCG Crossover GP I, LLC | 6.8M | 4.80% |
| 2025-11-14 | Point72 Asset Management, L.P. | 5.75M | 4.00% |
| 2025-08-14 | Venrock Healthcare Capital Partners II, L.P. | 4.76M | 4.20% |
| 2025-08-14 | Commodore Capital LP | 5.27M | 4.60% |
| 2025-08-14 | Paradigm BioCapital Advisors LP | 10.35M | 9.10% |
| 2025-08-14 | Commodore Capital LP | 6.41M | 5.50% |
| 2025-07-14 | Fairmount Funds Management LLC | 14.32M | 9.90% |
| 2025-07-14 | Fairmount Healthcare Fund II GP LLC | 14.32M | 9.90% |
| 2025-07-11 | Deerfield Mgmt, L.P. | 9.05M | 6.49% |
| 2025-05-15 | Paradigm BioCapital Advisors LP | 8.96M | 7.90% |
| 2025-04-11 | Venrock Healthcare Capital Partners II, L.P. | 6.45M | 5.80% |
| 2025-02-14 | Point72 Asset Management, L.P. | 9.99M | 8.70% |
| 2025-02-12 | Paradigm BioCapital Advisors LP | 5.56M | 5.00% |
| 2025-02-12 | FMR LLC | 16.57M | 15.00% |
| 2024-02-14 | Kynam Capital Management, LP | 5.85M | 6.80% |
| 2024-02-14 | Kynam Capital Management GP, LLC | 5.85M | 6.80% |
| 2024-02-14 | Yue Tang | 5.85M | 6.80% |
| 2024-02-13 | The Vanguard Group - 23-1945930 | 4.53M | 5.27% |
| 2024-02-09 | Abigail P. Johnson | 5.3M | 6.16% |
| 2024-02-09 | FMR LLC | 5.3M | 6.16% |
| 2024-02-05 | Suvretta Capital Management, LLC | 5.48M | 6.40% |
| 2024-02-05 | Aaron Cowen | 5.48M | 6.40% |
| 2024-02-05 | Averill Master Fund, Ltd. | 4.87M | 5.70% |
| 2023-06-01 | Point72 Asset Management, L.P. | 3.56M | 5.00% |
| 2023-06-01 | Steven A. Cohen | 3.56M | 5.00% |
| 2023-06-01 | Point72 Capital Advisors, Inc. | 3.56M | 5.00% |
| 2023-02-03 | STATE STREET CORPORATION | 4.26M | 6.10% |
| 2023-02-03 | (1) BlackRock, Inc. | 4.95M | 7.10% |
| 2022-09-06 | RA Capital Management, L.P. | 3.61M | 5.49% |
| 2022-09-06 | RA Capital Healthcare Fund, L.P. | 3.61M | 5.49% |
| 2022-09-06 | Peter Kolchinsky | 3.61M | 5.49% |
| 2022-09-06 | Rajeev Shah | 3.61M | 5.49% |
| 2022-07-08 | (1) BlackRock, Inc. | 3.3M | 3.80% |
| 2022-06-21 | Fairmount Healthcare Fund GP LLC | 3.27M | 4.90% |
| 2022-06-21 | Fairmount Funds Management LLC | 15.23M | 19.99% |
| 2022-06-21 | Fairmount Healthcare Fund II GP LLC | 14.94M | 19.61% |
| 2022-06-17 | Deerfield Mgmt, L.P. | 5.88M | 9.64% |
| 2022-06-17 | Company, L.P. | 5.88M | 9.64% |
| 2022-06-17 | Deerfield Partners, L.P. | 5.88M | 9.64% |
| 2022-06-17 | James E. Flynn | 5.88M | 9.64% |
| 2022-03-01 | Albert Cha | 2.19M | 5.50% |
| 2022-03-01 | James Brush | 2.19M | 9.00% |
| 2022-03-01 | James N. Topper | 2.19M | 5.50% |
| 2022-03-01 | Frazier Life Sciences Public Fund L.P. | 2.19M | 5.50% |
| 2022-03-01 | FHMLSP, L.P. | 2.19M | 5.50% |
| 2022-03-01 | FHMLSP, L.L.C | 2.19M | 5.50% |
| 2022-03-01 | Patrick J. Heron | 2.19M | 5.50% |
| 2022-02-14 | Logos Opportunities GP LLC | 150K | 11.00% |
| 2022-02-14 | BVF Partners L.P. | 3.11M | 7.50% |
| 2022-02-14 | Ridgeback Capital Management LLC 42-1684320 | - | 0.00% |
| 2022-02-14 | Ridgeback Capital Investments LLC 72-1614961 | - | 0.00% |
| 2022-02-14 | Robin C. John | 3.51M | 8.80% |
| 2022-02-14 | Eventide Asset Management, LLC | 3.51M | 8.80% |
| 2022-02-14 | Biotechnology Value Fund, L.P. | 1.7M | 4.20% |
| 2022-02-14 | Arsani William | 150K | 11.00% |
| 2022-02-14 | Graham Walmsley | 150K | 11.00% |
| 2022-02-14 | Logos GP LLC | 150K | 11.00% |
| 2022-02-14 | Finny Kuruvilla, M.D. Ph. D. | 3.51M | 8.80% |
| 2022-02-14 | Ridgeback Capital Investments L.P. 66-0677421 | - | 0.00% |
| 2022-02-14 | Biotechnology Value Fund II, L.P. | 1.19M | 3.00% |
| 2022-02-14 | BVF II GP LLC | 1.19M | 3.00% |
| 2022-02-14 | Biotechnology Value Trading Fund OS LP | 185.67K | 1.00% |
| 2022-02-14 | BVF Partners OS Ltd. | 185.67K | 1.00% |
| 2022-02-14 | BVF GP Holdings LLC | 2.89M | 7.00% |
| 2022-02-14 | BVF Inc. | 3.11M | 7.50% |
| 2022-02-14 | Mark N. Lampert | 3.11M | 7.50% |
| 2022-02-14 | VHCP Co-Investment Holdings II, LLC | 4.3M | 9.99% |
| 2022-02-14 | Venrock Healthcare Capital Partners III, L.P. | 4.3M | 9.99% |
| 2022-02-14 | VHCP Co-Investment Holdings III, LLC | 4.3M | 9.99% |
| 2022-02-14 | VHCP Management II, LLC | 4.3M | 9.99% |
| 2022-02-14 | VHCP Management III, LLC | 4.3M | 9.99% |
| 2022-02-14 | Shah, Nimish | 4.3M | 9.99% |
| 2022-02-14 | Koh, Bong | 4.3M | 9.99% |
| 2022-02-14 | Commodore Capital LP | 2.28M | 5.70% |
| 2022-02-14 | Commodore Capital Master LP | 2.28M | 5.70% |
| 2022-02-14 | Logos Global Opportunities Fund II LP | 150K | 11.00% |
| 2022-02-14 | Logos Global Management LP | 150K | 11.00% |
| 2022-02-14 | Logos Global Management GP LLC | 150K | 11.00% |
| 2022-02-14 | BVF I GP LLC | 1.7M | 4.20% |
| 2022-02-14 | Venrock Healthcare Capital Partners II, L.P. | 4.3M | 9.99% |
| 2022-02-11 | Ally Bridge MedAlpha Management GP, LLC | - | 0.00% |
| 2022-02-11 | Ally Bridge Group (NY) LLC | 1.5M | 3.80% |
| 2022-02-11 | ABG Management Ltd. | 1.5M | 3.80% |
| 2022-02-11 | Ally Bridge MedAlpha Master Fund L.P. | 1.5M | 3.80% |
| 2022-02-11 | EIN #00-0000000 | 2.52M | 6.30% |
| 2022-02-11 | Fan Yu | 1.5M | 3.80% |
| 2022-02-11 | Ally Bridge MedAlpha Management L.P. | - | 0.00% |
| 2022-02-04 | (1) BlackRock, Inc. | 2.7M | 6.80% |
| 2022-01-25 | (a) ¨ | 916.2K | 2.30% |
| 2022-01-25 | (a) ¨ | 916.2K | 2.30% |
| 2022-01-25 | (a) ¨ | 916.2K | 2.30% |
| 2021-11-17 | TCG Crossover Management, LLC | 2.72M | 6.80% |
| 2021-11-04 | Commodore Capital LP | 2.14M | 5.40% |
| 2021-11-04 | Commodore Capital Master LP | 2.14M | 5.40% |
| 2021-07-08 | TCG Crossover Management, LLC | 2.01M | 5.20% |
| 2021-02-16 | 2. | 1.25M | 5.20% |
| 2021-02-16 | 2. | 1.25M | 5.20% |
| 2021-02-16 | 2. | 1.25M | 5.20% |
| 2021-02-12 | RTW Master Fund, Ltd. | 1.4M | 2.21% |
| 2021-02-12 | Roderick Wong | 2M | 3.17% |
| 2021-02-12 | 1,622,591 | 1.62M | 5.10% |
| 2021-02-12 | 1,622,591 | 1.62M | 5.10% |
| 2021-02-12 | 1,622,591 | 1.62M | 5.10% |
| 2021-02-12 | 1,622,591 | 1.62M | 5.10% |
| 2021-02-12 | 1,622,591 | 1.62M | 5.10% |
| 2021-02-12 | 1,622,591 | 1.62M | 5.10% |
| 2021-02-12 | RTW Investments, LP | 2M | 3.17% |
| 2021-02-02 | Atlas Venture Associates IX, LLC | 916.2K | 8.08% |
| 2021-02-02 | Atlas Venture Fund IX, L.P. | 916.2K | 8.08% |
| 2021-02-02 | Atlas Venture Associates IX, L.P. | 916.2K | 8.08% |
| 2020-12-03 | RTW Investments, LP | 1.26M | 9.99% |
| 2020-12-03 | RTW Master Fund, Ltd. | 883.75K | 7.01% |
| 2020-12-03 | Roderick Wong | 1.26M | 9.99% |
| 2020-11-19 | Ally Bridge MedAlpha Master Fund L.P. | 1.42M | 8.03% |
| 2020-11-19 | Fan Yu | 1.42M | 8.03% |
| 2020-11-19 | ABG Management Ltd. | 1.42M | 8.03% |
| 2020-11-19 | Ally Bridge Group (NY) LLC | 1.42M | 8.03% |
| 2020-11-19 | Ally Bridge MedAlpha Management GP, LLC | 1.42M | 8.03% |
| 2020-11-19 | Ally Bridge MedAlpha Management L.P. | 1.42M | 8.03% |
| 2020-09-08 | Logos Global Management LP | 1.93M | 11.00% |
| 2020-08-19 | VHCP Co-Investment Holdings II, LLC | 4.36M | 11.40% |
| 2020-08-19 | Venrock Healthcare Capital Partners II, L.P. | 4.36M | 11.40% |
| 2020-08-19 | VHCP Management III, LLC | 4.36M | 11.40% |
| 2020-08-19 | Koh, Bong | 4.36M | 11.40% |
| 2020-08-19 | Shah, Nimish | 4.36M | 11.40% |
| 2020-08-19 | VHCP Management II, LLC | 4.36M | 11.40% |
| 2020-08-19 | Venrock Healthcare Capital Partners III, L.P. | 4.36M | 11.40% |
| 2020-08-19 | VHCP Co-Investment Holdings III, LLC | 4.36M | 11.40% |
| 2020-07-20 | VHCP Management II, LLC | 1.89M | 5.00% |
| 2020-07-20 | Venrock Healthcare Capital Partners II, L.P. | 1.89M | 5.00% |
| 2020-07-20 | VHCP Co-Investment Holdings III, LLC | 1.89M | 5.00% |
| 2020-07-20 | Shah, Nimish | 1.89M | 5.00% |
| 2020-07-20 | Koh, Bong | 1.89M | 5.00% |
| 2020-07-20 | Venrock Healthcare Capital Partners III, L.P. | 1.89M | 5.00% |
| 2020-07-20 | VHCP Co-Investment Holdings II, LLC | 1.89M | 5.00% |
| 2020-07-20 | VHCP Management III, LLC | 1.89M | 5.00% |
| 2020-07-16 | 42-1684320 | 2.4M | 6.20% |
| 2020-07-16 | Biotechnology Value Fund, L.P. | 4.15M | 9.99% |
| 2020-07-16 | BVF I GP LLC | 4.15M | 9.99% |
| 2020-07-16 | Biotechnology Value Fund II, L.P. | - | 0.00% |
| 2020-07-16 | BVF II GP LLC | - | 0.00% |
| 2020-07-16 | Biotechnology Value Trading Fund OS LP | - | 0.00% |
| 2020-07-16 | BVF Inc. | 4.15M | 9.99% |
| 2020-07-16 | BVF Partners OS Ltd. | - | 0.00% |
| 2020-07-16 | BVF GP HOLDINGS LLC | 4.15M | 9.99% |
| 2020-07-16 | BVF Partners L.P. | 4.15M | 9.99% |
| 2020-07-16 | Mark N. Lampert | 4.15M | 9.99% |
| 2020-07-16 | 00-0000000 | 2.4M | 6.20% |
| 2020-07-16 | 00-0000000 | 2.4M | 6.20% |
| 2020-07-10 | Fairmount Healthcare Fund II GP LLC | 6.11M | 16.31% |
| 2020-07-10 | Fairmount Funds Management LLC | 7.48M | 19.99% |
| 2020-07-10 | Fairmount Healthcare Fund GP LLC | 1.38M | 3.68% |
| 2020-02-10 | SANOFI | 842.05K | 2.75% |
| 2020-02-04 | (a) ¨ | 3.36M | 10.96% |
| 2020-02-04 | (a) ¨ | 3.36M | 10.96% |
| 2020-02-04 | (a) ¨ | 3.36M | 10.96% |
| 2019-03-08 | (1) BlackRock, Inc. | 1.49M | 4.98% |
| 2019-02-11 | 5.91% | 1.77M | 12.00% |
| 2019-02-08 | Atlas Venture Associates IX, LLC | 3.36M | 11.21% |
| 2019-02-08 | Atlas Venture Fund IX, L.P. | 3.36M | 11.21% |
| 2019-02-08 | Atlas Venture Associates IX, L.P. | 3.36M | 11.21% |
| 2019-02-08 | (1) BlackRock, Inc. | 1.53M | 5.10% |
COGT Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $35.52 | 67.6M | $2.4B | $312.01M | $253.15M | $2.34B |
| 2024-12-31 | $7.80 | 103.86M | $810.08M | $98.16M | $17.47M | $729.38M |
| 2023-12-31 | $5.88 | 79.66M | $468.38M | $53.23M | $18.85M | $434.01M |
| 2022-12-31 | $11.56 | 58.74M | $679.03M | $139.89M | $19.65M | $558.79M |
| 2021-12-31 | $8.58 | 38.73M | $332.31M | $219.68M | $3.16M | $115.78M |
| 2020-12-31 | $11.23 | 11.08M | $124.44M | $242.19M | $5.21M | -$112.54M |
| 2019-12-31 | $2.88 | 7.62M | $21.95M | $37.42M | $6.03M | -$9.45M |
| 2018-12-31 | $17.60 | 6.22M | $109.54M | $55.67M | -$ | $53.87M |
| 2017-12-31 | $44.44 | 7.4M | $328.7M | $28.27M | -$ | $300.43M |
| 2016-12-31 | $44.44 | 5.86M | $260.21M | $41.32M | -$ | $218.89M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $38.49 | 67.41M | $2.59B | $241.21M | $238.65M | $2.59B |
| 2025-12-31 | $35.52 | 67.6M | $2.4B | $312.01M | $253.15M | $2.34B |
| 2025-09-30 | $14.36 | 114.47M | $1.64B | $125.3M | $60.56M | $1.58B |
| 2025-06-30 | $7.18 | 114.47M | $821.87M | $127.6M | $60.66M | $754.93M |
| 2025-03-31 | $5.99 | 113.31M | $678.71M | $126M | $17.09M | $569.8M |
| 2024-12-31 | $7.80 | 110.46M | $861.6M | $98.16M | $17.47M | $780.9M |
| 2024-09-30 | $10.80 | 110.17M | $1.19B | $97.04M | $17.83M | $1.11B |
| 2024-06-30 | $8.94 | 99.24M | $887.21M | $88.22M | $18.18M | $817.17M |
| 2024-03-31 | $6.90 | 94.8M | $654.15M | $215.8M | $18.52M | $456.87M |
| 2023-12-31 | $5.88 | 86.73M | $509.97M | $53.23M | $18.85M | $475.6M |
| 2023-09-30 | $9.75 | 86.17M | $840.12M | $86.81M | $19.17M | $772.48M |
| 2023-06-30 | $11.84 | 74.75M | $885.08M | $214.32M | $19.36M | $690.12M |